Morningstar - Illinois Tool Works Inc. (ITW) Illinois Tool Works Efficiency Gains Drive Record Operating Earnings and 14% 3Q EPS Growth

Report

Morningstar

David Silver

EUR 101.80 For Business Accounts Only

Illinois Tool Works' Efficiency Gains Drive Record Operating Earnings and 14% 3Q EPS Growth

We are raising our fair value estimate for narrow-moat Illinois Tool Works to $132 from $120 to reflect higher forecast earnings tied to stronger assumptions for operating margins and currency translation. Our new fair value estimate remains roughly 13% below the current share price, reflecting the company's strong share price performance since 2015 and our moderate organic growth forecast.Â Â
Higher organic revenue growth and ongoing efficiency gains drove healthy 14% third-quarter EPS growth (e...

23/10/2017 13 EN

Underlying

Illinois Tool Works Inc.

Illinois Tool Works manufactures a range of industrial products and equipment. Automotive OEM segment produces components and fasteners for automotive-related applications. Food Equipment segment is engaged in commercial food equipment. Test and Measurement and Electronics segment produces equipment for testing and measuring of materials and structures. Welding segment produces arc welding equipment, consumables and accessories. Polymers and Fluids segment produces adhesives, sealants, lubrication and cutting fluids for auto aftermarket maintenance. Construction Products segment supplies fastening systems and solutions. Specialty Products segment is focused on patent protection.

See profile

US4523081093 New York Stock Exchange United States

Provider

Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

See profile

Analysts

David Silver

Other Reports on these Companies

GlobeNewsWire

ITW Board of Directors Approves Dividend Rate Increase

ITW Board of Directors Approves Dividend Rate Increase GLENVIEW, Ill., Aug. 01, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Illinois Tool Works Inc. (NYSE: ITW) authorized a seven percent increase to the dividend payout to shareholders, representing a quarterly increase of $0.11 per share – or $0.44 per share annually – versus the current dividend rate. The Board also declared a dividend on the company's common stock of $1.61 per share for the third quarter of 2025. The dividend equates to $6.44 per share on a full-year basis. The dividend will be paid on October 10, 2025 to shareh...

August 1, 2025 August 1, 2025 1 EN

GlobeNewsWire

ITW Reports Second Quarter 2025 Results

ITW Reports Second Quarter 2025 Results Revenue of $4.1 billion, an increase of 1% with flat organic growthOperating margin of 26.3% as enterprise initiatives contributed 130 bpsGAAP EPS of $2.58, a new Q2 recordRaising full year 2025 GAAP EPS guidance by $0.10; narrowing the range to $10.35 to $10.55 per share GLENVIEW, Ill., July 30, 2025 (GLOBE NEWSWIRE) -- Illinois Tool Works Inc. (NYSE: ITW) today reported its second quarter 2025 results and updated guidance for full year 2025. “The ITW team outpaced underlying end market growth and delivered solid financial per...

July 30, 2025 July 30, 2025 1 EN

GlobeNewsWire

ITW Schedules Second Quarter 2025 Earnings Webcast

ITW Schedules Second Quarter 2025 Earnings Webcast GLENVIEW, Ill., July 11, 2025 (GLOBE NEWSWIRE) -- Illinois Tool Works Inc. (NYSE: ITW) will issue its second quarter 2025 results on Wednesday, July 30, 2025, at 7:00 a.m. CDT. Following the release, ITW will hold its second quarter 2025 earnings webcast at 9:00 a.m. CDT. To access the webcast for the event, please click on the following link: If you are a participant on the conference call, please dial 1-888-660-6652 (domestic) or 1-646-960-0554 (international) 10 minutes prior to the 9:00 a.m. CDT start time. The passcode is “ITW....

July 11, 2025 July 11, 2025 1 EN

Business as Usual for No-Moat Lonza; Specialty Ingredients Carve-Out on Track for 2020

Contract manufacturer Lonza reported solid half-year results, with over CHF 2.9 billion in total sales year to date, up about 6.4% from last year and boosted by foreign exchange tailwinds. Core EBITDA margin expanded 30 basis points from last year to about 27.8%, helped slightly by new accounting standards. Management indicated that it continues to expect mid- to high-single-digit sales growth in 2019. We are maintaining our fair value estimate of CHF 210 per share and our no-moat rating. The ph...

EUR 100.00

July 25, 2019 July 25, 2019 13 EN

Joe Gemino

Joe Gemino

Sasol Provides Full-Year Production Update

No-moat Sasol provided an update on its full-year fiscal 2019 production metrics that included relatively stable liquids production. For the full year ended June 30, Sasol produced 1,470 thousand barrels of crude oil and condensate a day compared with 1,469 mboe/d in the year-ago period. However, declines continued with the companyâ€™s natural gas production, down 4% to 130.3 billion cubic feet compared with the period ended June 30, 2018. Sasol also reported flat refined products of 31.4 mmboe/d ...

EUR 100.00

July 25, 2019 July 25, 2019 12 EN

Damien Conover

Damien Conover

Astra Posts Solid 2Q, Driven by Strong Cancer Drug Sales and Moving Away From One-Time Divestments

We don't expect any major changes to our AstraZeneca fair value estimate following second-quarter results that largely fell in line with our expectations and slightly ahead of consensus expectations. Overall, the company is posting leading Big Pharma sales growth with total sales up 18% operationally year over year, led by impressive cancer drug sales growth of 57%. Astra's ability to continue to bring next generation drugs to the market that address unmet medical need (especially in oncology) s...

EUR 100.00

July 25, 2019 July 25, 2019 14 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Illinois Tool Works' Efficiency Gains Drive Record Operating Earnings and 14% 3Q EPS Growth

ITW Board of Directors Approves Dividend Rate Increase

ITW Reports Second Quarter 2025 Results

ITW Schedules Second Quarter 2025 Earnings Webcast

Business as Usual for No-Moat Lonza; Specialty Ingredients Carve-Out on Track for 2020

Sasol Provides Full-Year Production Update

Astra Posts Solid 2Q, Driven by Strong Cancer Drug Sales and Moving Away From One-Time Divestments

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe